Investigating the disparities among drug categories in drug-induced dermatomyositis: A systematic review
Authors' conclusion
In conclusion, our review consolidates the current literature on DIDM, highlighting the evolving spectrum of medications and elucidating the differences in clinical manifestations, laboratory findings, and underlying mechanisms.
Study context
- Population
- Published cases of drug-induced dermatomyositis (DM) (drug-induced dermatomyositis (DIDM)), English literature
- Participants
- 69 published DIDM cases
- Comparison
- Biologics vs traditional drugs as causes of drug-induced DM
- Biologicsn = 33
- Traditional drugsn = 36reference
- Outcome
- Published DIDM cases by causative drug category (biologics vs traditional drugs) and history of malignancy
Methodological detailsliterature search of Pubmed, EMBASE and MEDLINE, English literature
- Literature search of Pubmed, EMBASE and MEDLINE
- English literature
Pooled result
As reported in the abstract
Biologics
33
events
Traditional drugs
36
events
- Total published DIDM cases documented
- 69
- DIDM cases with a previous history of malignancies
- 41
Original publication
Investigating the disparities among drug categories in drug-induced dermatomyositis: A systematic review. Semin Arthritis Rheum. Published 27 May 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →